
|Articles|January 19, 2016
ICON’s Flex Advantage IRT Platform
Flex Advantage offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
Advertisement
ICON has announced Flex Advantage, its next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities to support adaptive trials.
Flex Advantage features:
- Randomization engine that can be adjusted mid-study or dynamically
- Plug-and-play modules for easier configuration
- Emergency unblinding support
- Enhanced reporting with customizable dashboard
- Integration with ICON products, such as ADDPLAN, Firecrest and ICONIK as well as external EDC, drug distributor and drug supply forecasting systems
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
2025 Veeva R&D and Quality Summit: Effectively Utilizing Clinical Reference Data
3
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
4
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
5





.png)



.png)



.png)
.png)
